|
Cholera - Pipeline Review, H1 2019 |
Jan 31 2019 |
47 |
Global |
$2,000.00 |
|
|
Obsessive-Compulsive Disorder - Pipeline Review, H1 2019 |
Jan 31 2019 |
39 |
Global |
$2,000.00 |
|
|
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2019 |
Jan 31 2019 |
51 |
Global |
$2,000.00 |
|
|
Bacterial Vaginosis - Pipeline Review, H1 2019 |
Jan 31 2019 |
61 |
Global |
$2,000.00 |
|
|
Tourette syndrome - Pipeline Review, H1 2019 |
Jan 31 2019 |
72 |
Global |
$2,000.00 |
|
|
Otitis Media - Pipeline Review, H1 2019 |
Jan 31 2019 |
60 |
Global |
$2,000.00 |
|
|
Lyme Disease - Pipeline Review, H1 2019 |
Jan 31 2019 |
46 |
Global |
$2,000.00 |
|
|
Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019 |
Jan 31 2019 |
44 |
Global |
$2,000.00 |
|
|
Hidradenitis Suppurativa - Pipeline Review, H1 2019 |
Jan 31 2019 |
157 |
Global |
$2,000.00 |
|
|
Typhoid Fever - Pipeline Review, H1 2019 |
Jan 31 2019 |
51 |
Global |
$2,000.00 |
|
|
Left Ventricular Dysfunction - Pipeline Review, H1 2019 |
Jan 31 2019 |
44 |
Global |
$2,000.00 |
|
|
Secondary Hyperparathyroidism - Pipeline Review, H1 2019 |
Jan 31 2019 |
58 |
Global |
$2,000.00 |
|
|
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2019 |
Jan 31 2019 |
35 |
Global |
$2,000.00 |
|
|
Hypotension - Pipeline Review, H1 2019 |
Jan 31 2019 |
50 |
Global |
$2,000.00 |
|
|
Nocturia - Pipeline Review, H1 2019 |
Jan 31 2019 |
46 |
Global |
$2,000.00 |
|
|
Primary Biliary Cirrhosis - Pipeline Review, H1 2019 |
Jan 31 2019 |
128 |
Global |
$2,000.00 |
|
|
Pancreatic Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
2787 |
Global |
$2,500.00 |
|
|
Melanoma - Pipeline Review, H2 2018 |
Dec 21 2018 |
2285 |
Global |
$2,500.00 |
|
|
Cervical Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
1026 |
Global |
$2,000.00 |
|
|
Colorectal Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
2548 |
Global |
$2,500.00 |
|
|
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H2 2018 |
Nov 20 2018 |
67 |
Global |
$3,500.00 |
|
|
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
35 |
Global |
$3,500.00 |
|
|
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2018 |
Nov 20 2018 |
48 |
Global |
$3,500.00 |
|
|
Radiodermatitis - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$2,000.00 |
|
|
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
68 |
Global |
$3,500.00 |
|
|
Diabetic Foot Ulcers - Pipeline Review, H2 2018 |
Nov 20 2018 |
138 |
Global |
$2,000.00 |
|
|
cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$3,500.00 |
|
|
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H2 2018 |
Nov 20 2018 |
79 |
Global |
$3,500.00 |
|
|
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
32 |
Global |
$3,500.00 |
|
|
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H2 2018 |
Nov 20 2018 |
86 |
Global |
$3,500.00 |
|
